A carregar...
COVID-19: Antiviral agents and enzyme inhibitors/receptor blockers in development
Novel 2019 coronavirus (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2]) and coronavirus disease 2019 (COVID-19), the respiratory syndrome it causes, have shaken the world to its core by infecting and claiming the lives of many people since originating in December 2019 in Wuhan, China....
Na minha lista:
| Publicado no: | Exp Biol Med (Maywood) |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8283249/ https://ncbi.nlm.nih.gov/pubmed/33757336 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370221999989 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|